dihydroceramide and Glucose-Intolerance

dihydroceramide has been researched along with Glucose-Intolerance* in 1 studies

Other Studies

1 other study(ies) available for dihydroceramide and Glucose-Intolerance

ArticleYear
Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans.
    Cell reports, 2017, 02-28, Volume: 18, Issue:9

    Plasma metabolite concentrations reflect the activity of tissue metabolic pathways and their quantitative determination may be informative about pathogenic conditions. We searched for plasma lipid species whose concentrations correlate with various parameters of glucose homeostasis and susceptibility to type 2 diabetes (T2D). Shotgun lipidomic analysis of the plasma of mice from different genetic backgrounds, which develop a pre-diabetic state at different rates when metabolically stressed, led to the identification of a group of sphingolipids correlated with glucose tolerance and insulin secretion. Quantitative analysis of these and closely related lipids in the plasma of individuals from two population-based prospective cohorts revealed that specific long-chain fatty-acid-containing dihydroceramides were significantly elevated in the plasma of individuals who will progress to diabetes up to 9 years before disease onset. These lipids may serve as early biomarkers of, and help identify, metabolic deregulation in the pathogenesis of T2D.

    Topics: Adult; Aged; Animals; Biomarkers; Blood Glucose; Ceramides; Diabetes Mellitus, Type 2; Disease Susceptibility; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Middle Aged; Prospective Studies; Sphingolipids

2017